Literature DB >> 15325251

Photosensitization with protoporphyrin IX inhibits attachment of cancer cells to a substratum.

A B Uzdensky1, A Juzeniene, E Kolpakova, G-O Hjortland, P Juzenas, J Moan.   

Abstract

Effects of photodynamic therapy (PDT) on adhesion of human adenocarcinoma cells of the line WiDr to a plastic substratum were investigated. Protoporphyrin IX induced by 5-aminolevulinic acid (ALA) was used as a photosensitizer. Light exposure inhibited attachment of suspended cells to a substratum. The adhesion was most strongly pronounced for light exposures around 200 mJ/cm(2) causing cell death. However, sub-lethal exposures (42 mJ/cm(2), 97% survival) inhibited cell adhesion as well. Sub-lethal ALA-PDT increased the intracellular space in dense colonies of WiDr cells. This was attributed to formation of lamellipodia between the cells and to increased numbers of focal contacts containing alpha(V)beta(3) integrin in some of the cells. The E-cadherin distribution was not changed by the treatment. Complex processes, including changes in cellular shape and reorganization of the cytoskeleton, are suggested to participate in the observed ALA-PDT effect on the cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325251     DOI: 10.1016/j.bbrc.2004.07.132

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration.

Authors:  Xiaolan Feng; Pan Wang; Quanhong Liu; Ting Zhang; Bingjie Mai; Xiaobing Wang
Journal:  J Bioenerg Biomembr       Date:  2015-01-29       Impact factor: 2.945

2.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

3.  Sodium butyrate increases the effect of the photodynamic therapy: a mechanism that involves modulation of gene expression and differentiation in astrocytoma cells.

Authors:  José Bueno-Carrazco; Violeta Castro-Leyva; Fanny García-Gomez; Mario Solís-Paredes; Eva Ramon-Gallegos; Alfredo Cruz-Orea; Pilar Eguía-Aguilar; Francisco Arenas-Huertero
Journal:  Childs Nerv Syst       Date:  2012-06-19       Impact factor: 1.475

Review 4.  Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

Authors:  Nazareth Milagros Carigga Gutierrez; Núria Pujol-Solé; Qendresa Arifi; Jean-Luc Coll; Tristan le Clainche; Mans Broekgaarden
Journal:  Cancer Metastasis Rev       Date:  2022-09-26       Impact factor: 9.237

5.  Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.

Authors:  Adriana Casas; Gabriela Di Venosa; Silvia Vanzulli; Christian Perotti; Leandro Mamome; Lorena Rodriguez; Marina Simian; Angeles Juarranz; Osvaldo Pontiggia; Tayyaba Hasan; Alcira Batlle
Journal:  Cancer Lett       Date:  2008-07-26       Impact factor: 8.679

6.  Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy?

Authors:  Jonathan P Celli
Journal:  Isr J Chem       Date:  2012-07-24       Impact factor: 3.333

7.  Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line.

Authors:  Seema Gupta; Bilikere S Dwarakanath; K Muralidhar; Tulay Koru-Sengul; Viney Jain
Journal:  J Transl Med       Date:  2010-04-30       Impact factor: 5.531

8.  Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview.

Authors:  Angela Chiaviello; Ilaria Postiglione; Giuseppe Palumbo
Journal:  Cancers (Basel)       Date:  2011-03-03       Impact factor: 6.639

9.  Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.

Authors:  Xue Yang; Pratheeba Palasuberniam; Kenneth A Myers; Chenguang Wang; Bin Chen
Journal:  Oncotarget       Date:  2016-09-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.